Literature DB >> 15477929

The bioavailability of coenzyme Q10 supplements available in New Zealand differs markedly.

Sarah Molyneux, Christopher Florkowski, Michael Lever, Peter George.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15477929

Source DB:  PubMed          Journal:  N Z Med J        ISSN： 0028-8446


× No keyword cloud information.
  6 in total

1.  Coenzyme Q10 supplementation for the treatment of statin-associated muscle symptoms.

Authors:  Wilson Chen; Heather M Ochs-Balcom; Changxing Ma; Paul J Isackson; Georgirene D Vladutiu; Jasmine A Luzum
Journal:  Future Cardiol       Date:  2022-03-17

2.  Coenzyme Q10: is there a clinical role and a case for measurement?

Authors:  Sarah L Molyneux; Joanna M Young; Christopher M Florkowski; Michael Lever; Peter M George
Journal:  Clin Biochem Rev       Date:  2008-05

Review 3.  Coenzyme Q10 for the treatment of heart failure: a review of the literature.

Authors:  James J DiNicolantonio; Jaikrit Bhutani; Mark F McCarty; James H O'Keefe
Journal:  Open Heart       Date:  2015-10-19

Review 4.  Coenzyme Q10 Supplementation in Aging and Disease.

Authors:  Juan D Hernández-Camacho; Michel Bernier; Guillermo López-Lluch; Plácido Navas
Journal:  Front Physiol       Date:  2018-02-05       Impact factor: 4.566

Review 5.  Coenzyme Q10: Clinical Applications in Cardiovascular Diseases.

Authors:  Alma Martelli; Lara Testai; Alessandro Colletti; Arrigo F G Cicero
Journal:  Antioxidants (Basel)       Date:  2020-04-22

6.  A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease.

Authors:  Andrew J Duncan; Maria Bitner-Glindzicz; Brigitte Meunier; Harry Costello; Iain P Hargreaves; Luis C López; Michio Hirano; Catarina M Quinzii; Michael I Sadowski; John Hardy; Andrew Singleton; Peter T Clayton; Shamima Rahman
Journal:  Am J Hum Genet       Date:  2009-04-16       Impact factor: 11.025
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.